CEO Interviews | The Wall Street Analyzer - Part 4

Latest News

[ May 2, 2025 ] Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results News Feed
[ April 30, 2025 ] Pasofino Gold Announces Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million News Feed
[ April 14, 2025 ] Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks Market News
[ April 11, 2025 ] Canadian Gold Corp. Doubles the Phase 4 Drill Program at Tartan Mine Following McEwen Mining Investment News Feed
[ April 11, 2025 ] Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens News Feed
[ March 25, 2025 ] Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants News Feed
[ March 20, 2025 ] Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview News Feed

Acutus Medical (NASDAQ: AFIB)

February 24, 2023 The Wall Street Analyzer Comments Off

Interview update with David Roman, CEO and President […]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX)

February 22, 2023 The Wall Street Analyzer Comments Off

Interview update with Rick Van Kirk, CEO
[…]

No Picture

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF)

February 22, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP)

February 16, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Castellum, Inc (NYSE American: CTM)

February 15, 2023 The Wall Street Analyzer Comments Off

Interview with Mark Fuller, CEO and President
[…]

No Picture

Candel Therapeutics (NASDAQ: CADL)

February 7, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

CEO Interviews

Power Nickel Inc. (TSX-V: PNPN)(OTCQB:CMETF)

February 6, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

BuildDirect.com Technologies (TSXV: BILD)

February 6, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF)

February 1, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

No Picture

FingerMotion (NASDAQ: FNGR)

January 31, 2023 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com